Time To Efficacy and Onset Of Action Of Linezolid

Time To Efficacy and Onset Of Action Of Linezolid In Skin and Soft Tissue Infections

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00147511

Enrollment

118

Registered

2005-09-07

Start date

2003-06-30

Completion date

2005-06-30

Last updated

2011-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gram-Positive Bacterial Infections, Skin and Connective Tissue Diseases

Brief summary

To assess the onset of action of linezolid

Interventions

DRUGlinezolid

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* suspected grampositive infection * fever \> 38 C

Exclusion criteria

* Infections to be treated successfully by surgical procedures

Design outcomes

Primary

Measure	Time frame
Time to defervescence	—

Secondary

Measure	Time frame
Reduction of CRP levels Reduction of leucocyte count	—

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026